Permit + premises timing
Finish the facility against a checklist, confirm permitted use and required inspections, and keep research/production separate from retail stock. Do not assume the planned November completion has occurred until verified.
Internal working plan · As of 20 October 2026
2027 is a year to stabilize cash, prove GolBi, and earn the right to scale.
PHYTOSPHERE has a strong mission and a credible innovation story. But the business reality is that GolBi is still in technical validation, permits are in progress, the facility is being finished, and unrestricted operating capital is tight. The plan must secure near-term revenue without risking grant compliance or prematurely scaling an unready product.
Planning principle: sell services and compliant products where possible; validate before product commercialization; defer capital-heavy R&D until funded.
One mission. Three different roles.FOCUS · PROOF · CASH
TerraSyncEarn near-term service revenue
PAGBITurn compliant stock into cash carefully
GolBiUse grant-funded validation to reduce risk
Microbial R&DPause until a separate budget exists
GolBi
TRL 4 · Not market-readyTechnical validation is the priority; do not forecast commercial GolBi revenue yet.Facility
30 m² planned18 m² research/production + 12 m² agrivet; completion before Nov 2026 is a target to verify.Compliance
Local + FPA steps pendingMayor’s permit not ready; dealer/repacker licensing in progress. Confirm product-specific requirements separately.Capital
Grant funds ≠ general working capitalNo additional operating budget reported. Ring-fence grant funds and inventory money.Start with the truth
The immediate problem is not lack of ideas. It is the gap between ideas and cash-generating, compliant operations.
Use the next 12 months to lower the cost of uncertainty. Don’t build all product lines at once. Give each business unit a clear job and a spending gate.
Commercialization gate
GolBi is not ready for commercial sale. FPA paperwork for dealer/repacker activities does not automatically mean GolBi itself is cleared for sale. Confirm applicable product registration or experimental-use pathway with FPA before sales, repacking, promotional claims or distribution.
GolBi is not ready for commercial sale. FPA paperwork for dealer/repacker activities does not automatically mean GolBi itself is cleared for sale. Confirm applicable product registration or experimental-use pathway with FPA before sales, repacking, promotional claims or distribution.
Cash discipline gate
The ₱158,000 DOST-TAPI award remains intact, as confirmed by the owner, and is ring-fenced for approved GolBi technology-validation activities. It has not been used for the building. Separately, approximately ₱70,000 was borrowed by the owner to fund building work; treat that as a borrowing/debt liability, not grant spending or paid-in equity. The award is restricted project funding, not general operating cash; purchases must follow the signed TAPI budget, procurement rules and reporting requirements.
The ₱158,000 DOST-TAPI award remains intact, as confirmed by the owner, and is ring-fenced for approved GolBi technology-validation activities. It has not been used for the building. Separately, approximately ₱70,000 was borrowed by the owner to fund building work; treat that as a borrowing/debt liability, not grant spending or paid-in equity. The award is restricted project funding, not general operating cash; purchases must follow the signed TAPI budget, procurement rules and reporting requirements.
Too many projects
GolBi, microbial agents, new botanical sources, TerraSync, Agrinexa and PAGBI cannot all receive equal capital and attention. Prioritize work that either earns cash soon or fulfills funded validation obligations.
Unproven economics
Do not infer profit from sales or a large proposed stock budget. Calculate contribution margin after purchase cost, freight, discounts, fees, spoilage/expiry and labor before buying or pricing.
Confidential adviser assessment
Red flags to fix—and assets to exploit.
This is an internal diagnosis, not public-facing marketing copy. Treat risks as decisions with deadlines and consequences.
1. No commercial GolBi revenue yet
GolBi is still in technical validation; the local business permit, FPA dealer/repacker path and facility readiness remain incomplete. Product validation is not sales authorization.
Required action: freeze commercial sales claims and unapproved selling/repacking. Obtain written confirmation of the exact regulatory path and evidence milestones.
2. Building debt creates repayment pressure
Approximately ₱70,000 for building work was funded through the owner’s own borrowing/debt—not from the ₱158,000 DOST-TAPI award. The TAPI award remains intact and reserved for approved GolBi validation. The finance risk is the debt’s repayment burden and any remaining construction cost, not a missing or diverted grant.
Required action: by 23 Oct 2026, record the lender/creditor, legal borrower, principal borrowed, interest/fees, repayment terms, due dates, payments made and current outstanding balance. Add only contractually due debt payments to the 13-week cash forecast. Keep the TAPI ledger separate.
3. Too many bets for current capital
GolBi, muscardines, new botanical sources, Agrinexa, TerraSync and PAGBI cannot all receive equal capital and founder time while cash is tight.
Required action: TerraSync = near-term cash; PAGBI = controlled retail pilot after authorization; GolBi = funded validation; microbial and new botanical development = pause unless separately funded.
4. TerraSync is the fastest low-capital test
Use existing web, app and automation skills to sell fixed-scope websites, maintenance, order workflows and small software implementation projects. Do not build more features before selling a paid project.
Required action: sell 3 clear offers; request deposits; measure hours, revisions, delivery time and contribution per project.
5. PAGBI can monetize local demand—but only with discipline
The ₱120,000 inventory envelope is not a reason to spend ₱120,000 immediately. Price-sensitive growers, input-price movement and expired stock can convert cash into dead inventory.
Required action: verify permits, obtain current supplier quotes, start with a small pilot lot, and replenish only after measured sell-through and positive margin.
6. DOST-TAPI and awards create credibility, not proof of demand
Use the grant to produce credible validation outputs and use award recognition to open doors to labs, institutions, funders and cooperatives—not as a substitute for independent testing or repeat purchases.
Required action: build a milestone-backed evidence pack with costs, methods, results, limitations and next funding need.
Hard rule: no microbial machines, new extraction equipment, large inventory reload, paid advertising campaign or new recurring software subscription until the project has an identified funding source and the 13-week cash forecast still covers committed obligations.
Market watch · 20 October 2026
Price and demand assumptions must be refreshed—not guessed.
Use public indicators as warning signals, but use current supplier quotations and actual customer buying behavior for purchasing decisions.
Required market-intelligence routine: before each PAGBI purchase, collect current quotes from up to 3 suppliers for important SKUs; record landed unit cost, freight, credit terms, expiry, expected days-to-sell and minimum margin. Reconfirm quotes older than 7 days. Review high-turn and slow-moving stock every week. The 7-day rule is a management control, not a market rule.
Sources: PSA Region XI, September 2026; Philippine Statistics Authority national CPI; FPA weekly pesticide and fertilizer prices.
Who we are
Vision, mission, and the four values that guide every decision.
To become Mindanao’s leading agricultural biotechnology inputs enterprise, advancing scalable, science-driven, and sustainable crop protection solutions for Filipino farmers.
To serve farmers with holistic and SMART crop protection inputs through sustainable biotechnology, research-driven innovation, and resource-efficient solutions that improve agricultural productivity and strengthen farming communities.
01
Innovative
Recognize opportunities and turn agricultural challenges into practical, science-based solutions.
02
Sustainability-Centered
Make long-term farm productivity, environmental responsibility, and resource conservation part of every decision.
03
Farmer-Centeredness
Create measurable value by solving farmers’ real problems at a price and service level they can use.
04
Resourcefulness
Use existing capital, skills, local resources, digital capabilities, and partnerships before buying more capacity.
Portfolio focus
Give each enterprise a different job in 2027.
Do not rely on an unapproved product to pay today’s bills. Build bridge revenue while the biotechnology work is validated and documented.
Priority 1 · Cash engine01
TerraSync — software and digital services
Use existing skills to sell defined, low-capital services before investing in a broader software platform.
- Website and landing-page builds for local SMEs, farms, agrivets and organizations.
- Website maintenance, product catalogues, order forms and lightweight inventory/order workflows.
- Agrinexa remains a beta/pilot until usage, willingness to pay and retention are proven.
Cash rule: quote in writing, scope clearly, collect a deposit (proposed baseline: 50%) before work, and bill milestones promptly.
Priority 2 · Conditional trade02
PAGBI Agrivet Supplies — small, fast-turning stock
Agrivet retail could generate nearer-term transactions, but inventory ties up cash and product sales depend on correct permits and compliant stock.
- Start with a narrow list of products supported by customer requests and supplier quotes.
- Compare at least 3 current supplier quotes for material items; monitor price, availability and expiry.
- Separate PAGBI books, inventory, cash and payables from PHYTOSPHERE’s research project.
Cash rule: no bulk buy until applicable local/FPA authorizations are in place and SKU-level contribution margin is calculated.
Priority 3 · Funded proof03
GolBi — technical validation, not sales forecasting
Keep the flagship product as the strategic asset, but make its next milestone evidence, consistency, documentation and compliance—not commercial volume.
- Protect and administer the intact DOST-TAPI award according to the approved project work plan and procurement rules.
- Complete grant-supported tests, maintain batch records and define acceptance criteria.
- Confirm the separate product-registration/authorization path and commercialization gates with FPA.
Gate to advance: documented technical evidence + consistent batches + regulatory clearance + viable unit economics.
Priority 4 · Defer unfunded work04
Microbial facility and other botanicals
Muscardine upgrades need machines/equipment that are not funded. Citronella and other botanical sources broaden the research workload before the lead product is ready.
- Freeze machine purchases and expansion of microbial production until separate funding or an institutional partner is secured.
- Keep new botanical sources at desk-research or very small, separately funded screening stage.
- Reopen these projects only after core GolBi milestones and cash/runway conditions are met.
Cash rule: no unbudgeted capex, no diverting TAPI grant funds, no parallel R&D program without a funded work plan.
Scale-readiness re-check
The reality-based score is lower—and more useful—than an optimistic growth score.
This is a provisional management estimate from the October 2026 facts you supplied, not an audited rating. Re-score when permits, revenue and test results are evidenced.
Strategy & Market Position
8/20Clear positioning, but paid product-market fit and repeatable revenue are not demonstrated.
Operations & Infrastructure
9/20Facility and supply capacity are not proven; SOPs and product consistency need evidence.
Team, Leadership & Culture
7/20Founder concentration and limited management coverage constrain simultaneous workstreams.
Financial Health & Capital
6/20Business is in the red; unrestricted cash runway and unit economics are not yet evidenced.
37.5%
Strict evidence-based re-rating: 30/80 (37.5%)
Provisional internal adviser score based on the current reality supplied by management—not an audit or third-party assessment. This is a warning light, not a measure of founder potential.
Method: Strategy & market 8/20; Operations & infrastructure 9/20; Team & organization 7/20; Financial health 6/20. Original rubric arithmetic is inconsistent; use this common 4-pillar × 4-criteria scale for the next quarterly reassessment. Upgrade a score only when there is evidence.
SWOT + root causes
Strong ambition and grant support—but cash, permissions and repeatable delivery are the bottlenecks.
Use the SWOT to choose what to do now, what to defer, and what needs outside help. It is an operating diagnosis, not a marketing claim.
S Strengths · inside the business
- Recognized PHYTOSPHERE brand and award history.
- DOST-TAPI support earmarked for GolBi technical validation.
- Founder has product-development, agriculture, and digital-service capabilities.
- Planned 30 m² location with research/production and retail zones.
- TerraSync and PAGBI create routes to earn revenue not dependent on GolBi launch.
Use it: convert existing recognition and skills into customer meetings, paid service jobs and credible validation outputs.
W Weaknesses · inside the business
- GolBi is not yet ready for commercialization; permits are incomplete.
- Building completion, quality systems, supplier capacity and regulatory path remain in progress.
- No additional operating budget; business is described as “in the red.”
- Approximately ₱70,000 of building work was funded through the owner’s own borrowing/debt, not the TAPI award. The ₱158,000 DOST-TAPI award remains intact and restricted to approved GolBi validation.
- Microbial equipment is absent; repeat purchase, product economics and steady revenue are unproven.
Root cause: several product and business directions are competing for a small amount of cash, time and operating capacity.
O Opportunities · outside the business
- Sell TerraSync digital work in small, deposit-funded projects.
- Open PAGBI to local growers with a narrow assortment after required permits are confirmed.
- Collaborate with qualified laboratories, universities, cooperatives and agricultural groups.
- Use AI-assisted records and website/order tools to reduce admin friction.
- Position GolBi’s next funding ask around completed validation milestones and a clear cost model.
Best fit now: low-capital services plus carefully controlled retail can bridge the business while the biotech asset is validated.
T Threats · outside the business
- Regulatory delays can postpone product sales even if a facility is ready.
- Established agrivet brands and price-sensitive growers can compress margins.
- Crop cycles, weather and seasonal raw materials can change demand and availability.
- Fuel/inflation pressure can change freight, input replacement costs and customer spending.
- Grant or compliance errors could damage project delivery, partner confidence and funding prospects.
Response: reprice using current quotes, hold smaller stock lots, document compliance, monitor cash weekly and build contingencies.
Market and price volatility
Plan around changing conditions, not a fixed forecast.
Recent official indicators show that agricultural output and business sentiment can move in either direction. They do not prove demand for PHYTOSPHERE’s own products; they support active monitoring.
−2.6%
Davao de Oro vegetable production · 2025
PSA reported vegetable production at 30,350.1 MT in 2025, down 2.6% from 2024. This can affect crop mix, growing cycles and input purchasing patterns.
PSA regional data ↗−0.2%
Davao Region vegetable/root crop volume · Q1 2026
Q1 production was 27,994.36 MT versus 28,037.23 MT in Q1 2025. Small regional changes can hide large crop-by-crop differences.
PSA Q1 situationer ↗Risk-aware
Business confidence and input costs
BSP reported that business confidence turned pessimistic in July 2026 amid oil-price and inflation concerns. Treat supplier prices, freight and customers’ purchasing power as moving variables.
BSP survey release ↗Weekly market-check routine
For PAGBI, obtain fresh quotes from at least 3 suppliers for core items; compare delivered cost against competitor prices and expected selling price; recalculate margin after freight, discounts, expiry/spoilage and payment fees. Review the FPA weekly price archive plus current supplier offers. For TerraSync, log lead source, quote acceptance, time spent, deposits, project profit and repeat requests monthly.
For PAGBI, obtain fresh quotes from at least 3 suppliers for core items; compare delivered cost against competitor prices and expected selling price; recalculate margin after freight, discounts, expiry/spoilage and payment fees. Review the FPA weekly price archive plus current supplier offers. For TerraSync, log lead source, quote acceptance, time spent, deposits, project profit and repeat requests monthly.
Confidential financial control tower
Know which capital is real, which is restricted, and which has not yet been reported.
Corrected finance baseline as reported by the owner on 20 October 2026: the ₱158,000 TAPI award remains intact and restricted to approved GolBi validation; approximately ₱70,000 for building works came from the owner’s own borrowing/debt. Reconcile the personal debt terms and available unrestricted operating cash separately before new commitments.
₱158,000
Entire award is for GolBi technical validation under the signed project scope. It is not general working capital.
Grant status: intact and reserved, per owner confirmation. The ~₱70,000 building expenditure was financed through the owner’s own borrowing/debt and does not reduce this award. Keep the grant ring-fenced for approved GolBi validation; every purchase must match an approved budget line, procurement requirements, delivery evidence and official receipt. Obtain written approval for any change in scope.
~₱70,000 borrowed for building
This amount is reported as the owner’s own borrowing used for building work—not TAPI spending and not paid-in equity. Keep it in a separate debt register and confirm who is legally liable under the loan or borrowing arrangement.
Not available cash. Record the actual outstanding amount, repayment dates, interest/fees and any arrears. Remaining completion cost is unknown; obtain a quote and identify a valid funding source or defer the work.
₱120,000 stock budget
For cash-conservative planning, reserve the owner-estimated ₱6,000 FPA fee inside the ₱120,000 envelope until the owner confirms it is extra and verifies the current official fee.
Provisional cap: ₱6,000 licensing reserve + maximum ₱114,000 total inventory; first-lot order capped at ₱30,000. All purchases depend on permits, verified cash and SKU economics. If ₱6,000 is extra, do not add it without proof of separate available funds.
Other confidential funds · report in Q1
Additional confidential funds are not quantified in this version. Owner to disclose source, amount, cash status, restrictions, repayment terms and liabilities in an internal report by 31 March 2027. No such funds are included in projected available cash or budgets before that report.
Required evidence: supporting statements/contracts; restriction classification; unrestricted cash calculation; approved use, if any.
No additional budget is assumed
The company is reported to be in the red. Until bank reconciliations prove otherwise, assume no unrestricted surplus. TerraSync jobs must be deposit-funded; PAGBI stock is phased; GolBi spends only within approved TAPI lines; microbial equipment and alternative botanical R&D receive ₱0 base-case capital.
Proposed TAPI budget control buckets
Planning caps total ₱158,000 — use only if they match the signed grant budget.
These are NOT claimed to be the approved budget split. Replace them with grant-agreement line items and written TAPI approval before procurement. If the signed grant uses different categories, the signed categories prevail.
| Proposed project bucket | Planning cap | Release condition | Evidence to file |
|---|---|---|---|
| External laboratory / analytical testing | ₱42,000 | Written scope, lab recognition/accreditation where required, quote, grant eligibility and approved purchase. | Lab quote, method, sample requirements, PO, report and invoice. |
| Eligible materials, reagents and validation consumables | ₱26,000 | Materials directly tied to the signed GolBi protocol; not PAGBI inventory or general operations. | Bill of materials, 2–3 quotes where applicable, PO, delivery record and usage log. |
| GolBi validation-specific equipment / safety items / workbench items | ₱36,000 | Only equipment/materials approved in the project; no civil construction or microbial equipment unless explicitly approved. | Technical specification, quotes, grant-officer authorization, inventory tag and receiving report. |
| Greenhouse / field validation materials | ₱24,000 | Approved trial protocol, access/permissions, sample size and dates, funding line eligibility. | Trial design, farm/greenhouse log, bills/receipts and observation sheets. |
| Repeat tests, QA documentation and report completion | ₱15,000 | Required by protocol/monitoring; any repeat test must be approved and balance confirmed. | Deviation note, repeat-test rationale, report checklist and receipt. |
| Re-test/price variance headroom | ₱15,000 | Not a free contingency. Use only if the grant budget allows and TAPI approves the specific spend in writing. | Updated quote, written approval and revised ledger. |
| TOTAL PROPOSED CAP | ₱158,000 | Award reported intact; use this proposed breakdown only if it matches the signed approved budget and TAPI confirms eligibility. | Grant ledger and monitoring pack. |
Weekly finance operating system
Four non-negotiable controls.
1. 13-week cash forecast every Monday
Start 26 Oct 2026. Include only confirmed collections; show due dates, payables, operating costs, contractually due owner-debt repayments and project-specific grant commitments. Separate unrestricted cash from grant cash and proposed stock allocations.
2. Close by the 5th working day
Reconcile bank, cash, sales, customer deposits, receivables, supplier invoices, stock and owner contributions. Report separate profit/loss for TerraSync, PAGBI and GolBi/TAPI.
3. Purchase-order test
No PO unless there is (a) cash source; (b) current quote; (c) positive contribution or approved R&D milestone; (d) permission; and (e) forecast coverage. Reconfirm supplier quotes older than 7 days for volatile items.
4. Insolvency trigger
If available unrestricted cash falls below 8 weeks of fixed operating costs after a proposed spend, freeze optional spending. Below 4 weeks: freeze all nonessential orders, focus on collecting receivables/deposits, renegotiate due dates early and prepare a 30-day survival budget.
Legal/technical gate: local business permits, FPA dealer/repacker licensing and GolBi’s own product authorization are separate checks. Do not sell, repack or promote GolBi for commercial use until the exact applicable authorizations are confirmed. Official application resources are at FPA downloadable forms ↗.
V. Action Plan · Confidential owner operating plan
Specific commitments, dates, budgets, sourcing routes and fail-safes.
This table is the execution document, not generic strategy. Every date is a management deadline proposed for the stated reality as of 20 October 2026. Costs are caps or planning scenarios; purchase only after funding, permit and grant gates are verified.
Funding facts, corrected: The ₱158,000 DOST-TAPI award remains intact and is reserved for approved GolBi technical validation, according to the owner. The approximately ₱70,000 building expenditure was funded through the owner’s own borrowing/debt, not the TAPI grant. Record and schedule that liability separately; do not deduct it from the grant. Other confidential funds will be reported internally by 31 March 2027 and are excluded from budgets until disclosed and classified.
How to use this: horizontal scroll is available. Each row names the deadline, budget control, a sourcing route/partner and the evidence that closes the task. “₱0” means no new money is authorized in the current base case—not that the activity has no economic cost.
| Focus Areas | Strategies | Activities · owner · deliverable | Timeline / deadline | Budget allocation | Potential partners / sourcing | Resources needed |
|---|---|---|---|---|---|---|
| 4. Financial Health Owner: founder unless delegated | Separate owner borrowing/debt, restricted grant funds and confidential funds | By 22 Oct 2026, open three ledger/cost centres: (A) owner borrowing/building debt, (B) DOST-TAPI restricted GolBi grant, (C) business operating cash, and (D) other confidential funds pending Q1 reporting. Record the ~₱70,000 borrowing used for building work as a liability, attach loan/borrowing evidence and construction receipts where available, and list due dates. On 23 Oct, refresh the 13-week cash forecast including legally due debt payments while keeping the intact TAPI award ring-fenced. | 21–23 Oct 2026; forecast refreshed every Monday; month-end close by 5th working day | ₱0 new spend. Approximately ₱70,000 was borrowed by the owner for building work; it is a debt/liability, not available cash, owner equity or TAPI expenditure. The ₱158,000 TAPI award remains intact and restricted to its approved validation scope. | Owner/founder; accountant/bookkeeper if available; DOST-TAPI project officer for grant treatment. | Borrowing agreement/messages, lender/creditor confirmation, construction receipts, loan repayment schedule, grant award and approved budget, separate ledgers, bank records and 13-week cash forecast. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Close facility defects before activating the site | By 23 Oct, conduct a room-by-room inspection of the 30 m² site: 18 m² research/production zone and 12 m² PAGBI retail zone. Make a signed punch list for floor/walls, ventilation, water/electricity, lighting, handwashing, pest-proofing, secure chemical storage, segregation, fire safety, access and waste handling. By 27 Oct, get a written contractor quote for every unfinished item. Target completion by 31 Oct only if feasible and safe; take dated photos. | Inspection 23 Oct; costed punch list 27 Oct; planned finish by 31 Oct 2026; reinspect 3 Nov | No new spend authorized until quote and cash source exist. The approximately ₱70,000 building expenditure was funded through owner borrowing/debt, not TAPI. Track repayment as a liability. Any remaining completion cost must have a separate confirmed funding source or be deferred; do not divert TAPI funds to construction. | Owner/founder; building contractor; Monkayo LGU/engineering and permitting counters; fire/safety office as applicable. | Floor plan, photos, contractor quotation, receipts, completion checklist, inspection/occupancy requirements. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Resolve mayor’s permit and exact FPA activity scope | On 23 Oct, visit/call Monkayo BPLO/Municipal Treasurer and request a written list of any remaining mayor’s permit requirements/status. On 26 Oct, email FPA RFU XI (rfu.region11@fpa.da.gov.ph) and request written confirmation of the licence needed for PAGBI to deal in pesticides/fertilizers, whether repacker activity is applicable, and the separate GolBi product authorization/registration or experimental-use pathway. Follow up 3 Nov and 10 Nov; record the case/reference and responsible officer. No regulated sale/repacking until applicable permits are actually issued. | 23 Oct–10 Nov 2026; status check every 2 weeks until resolved; decision gate 15 Jan 2027 | ₱0 assumed. User-reported PAGBI FPA fee reserve is ₱6,000; verify current fee and scope with FPA before payment. Existing permit payables/files reported as okay do not equal an issued permit. | Monkayo BPLO/Municipal Treasurer; FPA RFU Region XI; FPA Pesticide Regulations Division (prd@fpa.da.gov.ph); project owner. | Permit application, official receipts, valid IDs, lease/title documents, facility photos, written query, acknowledgement and official response. |
| 3. Organizational Strengthening Owner: founder unless delegated | Create an evidence-backed TAPI project control file | By 24 Oct 2026, assemble the award notice/agreement, approved project proposal/budget, owner-confirmed intact award status, authorized procurement records (if any), project timeline, required reports and monitoring dates. Record the ~₱70,000 building amount in the owner borrowing/debt register, not the TAPI ledger. Note that the ₱158,000 TAPI award remains intact and reserved for approved GolBi validation. By 31 Oct, confirm the upcoming milestone and procurement process with the project officer before ordering. | 24–31 Oct 2026; monthly grant-ledger/control check; reporting dates follow signed agreement | ₱158,000 award remains intact, as confirmed by the owner, and restricted to approved GolBi validation. It is not general operating cash. No procurement until each item maps to a signed budget line and the required approval; maintain transaction and monitoring records. | DOST-TAPI project officer; owner/founder; accountant/bookkeeper; vendors selected under the grant’s rules. | Grant agreement, approved budget, ledger, bank trail, statement of expenses, procurement/quotation records, milestone tracker. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Make TerraSync the first cash-generation experiment | By 28 Oct 2026, create 3 fixed offers and a one-page portfolio: (A) business website build/refresh starting test price ₱12,000, up to 5 pages; (B) lead/order/inventory workflow setup starting test price ₱18,000 after scope; (C) maintenance from ₱1,500/month plus third-party fees if any. Require written scope, 50% deposit, delivery date, and price for extra revisions. Track founder hours and direct costs; stop selling any offer with negative contribution. | Packages by 28 Oct 2026; prospect list 5 Nov; prospecting weekly Nov 2026–Dec 2027; monthly review | ₱0 paid advertising; no new software subscriptions. Allow up to ₱1,000 per paid project for direct delivery costs only if covered by customer deposit and approved in the quote. These are price tests, not proven market prices. | TerraSync founder/assigned delivery lead; local SMEs, farms, agrivets, cooperatives, schools and organizations as prospects—not confirmed partners. | Portfolio, rate card, proposal template, contract/scope template, invoice/deposit receipt, delivery checklist, time log, customer feedback form. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Build a measurable TerraSync lead pipeline | By 5 Nov 2026, list 30 named prospects with contact, sector, visible business problem and tailored offer. Each week contact at least 10 prospects and follow up twice over 10 business days. By 31 Dec aim for 4 discovery calls and 2 written quotes; by 31 Mar 2027, aim for at least 2 paid pilot projects with deposits. Focus direct outreach and referrals before any advertising. | Lead list 5 Nov 2026; weekly outreach; Q1 goal due 31 Mar 2027 | ₱0 advertising. Phone/data costs only from existing plan or collected client deposit; record expenses. Take at least 50% deposit for custom project work where commercially appropriate. | Monkayo/Nabunturan/Compostela small businesses; farm supply shops; farmer organizations; MonCAST/community network where appropriate; TerraSync. | CRM/Google Sheet, call/email scripts, follow-up dates, signed scope, quote-to-win log, cash collected report. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Source PAGBI inventory from verified licensed channels | By 7 Nov 2026, request written dealer/wholesale quotes from at least 3 potential suppliers: 2201 R.E.N. Corp., Davao City (official FPA list shows distributor/repacker roles; reported license expiry 12 Feb 2027—recheck after expiry); 2HJL Development Corp., Davao City (listed National Distributor through 4 Nov 2027—recheck live); and ABG Trading Corp., Panabo City (listed importer through 7 Mar 2027—ask whether they supply PAGBI directly). Also request a quote from Pacifica Agrivet only after verifying the relevant authorization/product channel. Quote sheet must contain product/brand, active ingredient, FPA registration number/expiry, pack size, minimum order, delivered price to Monkayo, payment terms, lot/expiry, delivery lead time and returns policy. | Quote requests 7 Nov 2026; comparison by 14 Nov; refresh every 30 days and before each order | ₱0 quote-gathering spend. Never use an old price as a purchase quote. FPA public license/product lists are the verification source—not a supplier endorsement. Supplier identities are leads, not confirmed approved vendors for every SKU. | FPA active licensed-handler list: https://fpa.da.gov.ph/resources/reports/licensed-handlers/ ; 2201 R.E.N., 2HJL Development, ABG Trading; Pacifica public website https://www.pacificaagrivet.com/; FPA registered-products list. | Quote request, official FPA handler screenshot/PDF, registered-product check, landed-cost and margin calculator, expiry/lot requirements. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Validate actual local demand before buying PAGBI stock | By 20 Nov 2026, interview 15 rice growers and 5 local farm-input buyers/retailers (with crop calendar and common pest problems captured). Ask top 10 purchased SKUs/active ingredients, brand/pack, normal price, monthly quantity, seasonality, credit expectations and most frequent stock-outs. By 31 Jan 2027, classify each SKU as A (requested repeatedly), B (seasonal), or C (no evidence); only A items enter the first-purchase shortlist. Conduct market research only until sales permissions are confirmed. | Interviews 10–20 Nov 2026; consolidate results by 27 Nov; update 31 Jan 2027 | ₱0 paid research; local travel only if included in existing funds and pre-approved. No inventory purchase linked to unverified demand. | Office of the Municipal Agriculturist—Monkayo (https://www.facebook.com/omagmonkayo/); Davao de Oro Provincial Agriculturist’s Office (https://davaodeoro.gov.ph/provincial-agricultures-office/); growers and agrivet buyers. | Interview script, anonymized customer records, crop/pest calendars, ranked SKU list, competing retail prices and evidence of buying frequency. |
| 4. Financial Health Owner: founder unless delegated | Lock the correct PAGBI capital treatment | By 14 Nov 2026, obtain current official FPA fee information and determine whether the planned ₱6,000 registration reserve is inside or outside the ₱120,000 stock envelope. Until the owner confirms otherwise, use the conservative scenario: ₱120,000 total PAGBI envelope, ₱6,000 reserved for licensing, and maximum total inventory budget ₱114,000. Do not call either figure “available cash” until bank balances and other obligations are reconciled. | Decision by 14 Nov 2026; recheck before payment | Conservative planning envelope ₱120,000 total: ₱6,000 permit reserve + up to ₱114,000 stock, subject to actual funds, official fees and licences. First purchase ceiling ₱30,000; keep at least ₱84,000 of the inventory allocation uncommitted after first tranche. | Owner/founder; FPA RFU XI; accountant/bookkeeper; suppliers in verified quote sheet. | Written fee advice, capital-source confirmation, 13-week cash forecast, budget approval, bank reconciliation. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Get external test quotations and a signed validation calendar | By 7 Nov 2026, send a one-page test matrix for GolBi to FPA RFU XI and the DOST XI Regional Standards and Testing Laboratory (DOST XI public contact: 082-227-1313; https://region11.dost.gov.ph/). Ask which tests fall within each lab’s accredited/recognized scope, required sample quantity, cost, turnaround and report format. For efficacy/bioefficacy, obtain the current FPA-recognized-lab list from FPA and confirm recognition in writing. By 15 Nov, get two written quotes per required test where feasible. By 28 Nov, submit the costed work plan and procurement schedule to TAPI; follow the signed work plan if it sets different dates. | Queries by 7 Nov; written quotes by 15 Nov; grant-compatible calendar by 28 Nov 2026 | The ₱158,000 TAPI award is reported intact but restricted. Do not order testing until grant eligibility, the signed budget line, written quote, test method and required approval are documented. Provisional planning caps only: lab/analytical tests ₱42,000; eligible trial materials/reagents ₱26,000; validation-specific equipment/safety tools ₱36,000; greenhouse/field materials ₱24,000; repeat test/documentation ₱15,000; approved re-test headroom ₱15,000 = ₱158,000 total. These are proposed ceilings only; signed TAPI budget overrides all proposed buckets. | DOST-TAPI project officer; DOST XI RSTL (scope confirmation required); FPA RFU XI (rfu.region11@fpa.da.gov.ph); FPA-recognized labs; test-material vendors. | Signed approved plan, lab scope/accreditation, quote comparisons, test protocol, samples/batch IDs, procurement forms and deliverable schedule. |
| 4. Financial Health Owner: founder unless delegated | Use a 13-week cash survival routine | Every Monday starting 26 Oct 2026, update cash at bank/in-hand, confirmed collections only, due payables, rent/utilities, taxes/permits, owner draws, committed grant expenses and potential inventory orders for the next 13 weeks. Close accounts by the 5th working day monthly and report by cost centre: TerraSync, PAGBI, GolBi/TAPI and other confidential funds. Use “zero new unrestricted capital” as base case until proved otherwise. | Every Monday; month-end close by 5th working day; monthly adviser review | ₱0 new spend. Freeze optional subscriptions, paid marketing, microbial capex, broad botanical R&D and inventory above the approved first tranche unless the forecast shows at least 8 weeks of fixed-cost coverage after spending. | Owner/founder; bookkeeper/accountant if available; business-unit leads. | Weekly cash tracker, bank statements, due-date ledger, debt/payable schedule, separate restricted-fund ledger and decision log. |
| 3. Organizational Strengthening Owner: founder unless delegated | Assign one owner and a proof artifact to every task | By 8 Jan 2027, maintain one action register with task ID, single accountable owner (founder until formally delegated), due date, status, budget authority, evidence link and next step. Hold a 30-minute Monday operating review and a 60-minute month-end review. Do not count an activity complete without its stated evidence (permit, quote, test report, receipt, customer deposit or completed checklist). | Register 8 Jan 2027; weekly Monday reviews all year | ₱0 new spend; use existing shared file/storage. | Founder; assign PAGBI day-to-day lead and technical-test lead in writing before launch/testing. | Task tracker; RACI/owner list; document folder; dated meeting notes and overdue-work list. |
| 4. Financial Health Owner: founder unless delegated | Report other confidential funds in Q1 without spending them in advance | By 31 Jan 2027, assemble an internal schedule of other confidential funds: source, amount, bank/location, restrictions, due dates, debt/repayment terms, and whether each item is cash, receivable, loan or restricted capital. Review the schedule monthly and complete the Q1 management report by 31 Mar 2027. Until disclosed/reconciled, assign no amount to the operating budget and do not use it to justify commitments. | Initial schedule 31 Jan; owner review 28 Feb; Q1 report due 31 Mar 2027 | No amount assigned; confidential amount marked “owner report pending.” No spend commitment until owner confirms liquidity, legal restrictions and obligations. | Owner/founder; accountant/bookkeeper; relevant funding source only if disclosure is required. | Confidential funds register stored in this protected portal; supporting statements/contracts; Q1 2027 internal funds report. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Reach Q1 TerraSync conversion targets | By 31 Jan 2027, contact 10 qualified prospects per week and hold at least 4 discovery calls in January. By 28 Feb, submit at least 4 written proposals cumulatively. By 31 Mar, close at least 2 paid projects with signed scope and customer deposits. Record actual delivery hours, project direct costs, revisions, collection date and margin. If 30 properly qualified contacts generate no sale, interview 5 lost prospects and change the offer before spending on advertising. | Weekly Jan–Mar; milestone checks 31 Jan, 28 Feb, 31 Mar | No paid advertising. Direct cost allowance max 25% of each collected deposit/revenue, unless a quote-specific exception is approved. Target initial price tests: ₱12,000 basic site; ₱18,000 workflow/business site; ₱1,500/month care—validate willingness to pay; these are not guaranteed market-clearing prices. | TerraSync; small businesses in Monkayo/Nabunturan/Compostela; agrivet shops, farms, local associations. | 30-lead list, CRM, discovery script, proposals, deposit invoices, hours log, post-project review. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Select PAGBI first-lot SKUs but do not bypass permits | By 15 Jan 2027, verify mayor’s permit status and the exact FPA licence/activity requirements with written evidence. By 31 Jan, complete 15 grower + 5 buyer interviews, score the 10 candidate rice-focused SKUs for demand, price, availability, expiry risk and net margin. By 15 Feb, compare three current supplier quotes and verify each selected SKU in FPA registered-products data. If applicable permit is not issued by 31 Mar, defer inventory purchase and continue only lawful, non-selling market research. | Permit decision checkpoint 15 Jan; SKU list 31 Jan; quote comparison 15 Feb; go/no-go 31 Mar | ₱0 stock spend in Q1 base plan unless all licences are issued, actual cash is verified, each SKU is registered and the 13-week forecast passes the purchase gate.₱6,000 registration reservation only after official fee confirmation. | FPA RFU XI; Monkayo BPLO; official FPA registered-product list https://fpa.da.gov.ph/resources/reports/registered-products/; licensed-handler quote leads in the action plan. | Written permits, farmer interview records, supplier quotes, registered-product proof, landed-cost spreadsheet, expiry and storage controls. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Start only the grant-approved GolBi validation activities | By 15 Jan 2027, receive TAPI confirmation of the governing milestone dates and allowed procurement lines. By 31 Jan, submit or confirm the protocol: target pest/crop, controls, replication, endpoints, phytotoxicity scoring, batch identifiers, acceptance criteria, data capture and reporting schedule. By 15 Feb, issue only grant-compliant purchase orders supported by approved quotes. From 1 Mar–30 Jun, run tests only on the approved calendar and record deviations immediately. No test date is deemed committed until lab slots and grant approvals are confirmed. | TAPI dates confirmed by 15 Jan; protocol 31 Jan; POs by 15 Feb; testing Mar–Jun subject to lab/TAPI availability | Up to the ₱158,000 intact award, but only for the approved TAPI scope and signed line-item budget. This is restricted validation funding, not general operating cash. Provisional proposal above may not replace the grant-approved budget; exclude civil construction, PAGBI inventory, TerraSync operations and microbial equipment unless specifically authorized in writing. | DOST-TAPI project officer; approved/recognized laboratory; FPA RFU XI; technical lead; test-material suppliers. | Approved grant budget; protocol; quotes; procurement approval; test schedule; sample chain of custody; raw-data sheets; invoice/receipt files. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Create batch and quality records before any product scale-up | By 31 Jan 2027, prepare version-controlled GolBi batch sheet and raw-material log with date, batch code, input source/lot, actual weights, process conditions, yield, appearance, deviations and operator. By 28 Feb, establish written preliminary acceptance limits with technical adviser/lab; do not invent limits retrospectively. By 30 Jun, assess three independently prepared batches only if permitted by the study protocol and budget. Any batch failure triggers root-cause documentation and a pause, not immediate commercial release. | Batch records 31 Jan; acceptance criteria 28 Feb; evaluation by 30 Jun | Use only approved grant-eligible validation materials. No machinery purchase in base case; rent/borrow/partner access first if compatible with protocol and safety. | DOST-TAPI; relevant test lab; researchers; approved suppliers. | SOPs, calibration/service certificates if relevant, balance/measurement logs, safety procedures, raw data and corrective-action forms. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Open PAGBI only after all permission and finance gates pass | By 15 Apr 2027, make a written GO/NO-GO decision using permits, cash forecast, registered product checks, supplier quotes and demand interviews. Only if all pass, purchase a first lot capped at ₱30,000. Enter every item by SKU, active ingredient, registration no., lot, expiry, landed cost and selling price. Do not repackage pesticides. If any permit gate fails, spend ₱0 on stock and revisit by the last business day of each month. | Formal GO/NO-GO by 15 Apr; first lot only after all gates; monthly review through Dec | First lot ≤₱30,000 from verified PAGBI funds. Conservative overall envelope: ₱120,000 including ₱6,000 fee reserve (thus ≤₱114,000 inventory total); if owner confirms the ₱6,000 is additional, update the budget only after proof of extra available cash. | FPA; Monkayo BPLO; verified supplier(s) from official handler lists; local farmers/retail buyers. | Permits; supplier invoice; active product registration; storage segregation; stock ledger; POS/sales ledger; receipts. |
| 4. Financial Health Owner: founder unless delegated | Prove stock turns before releasing remaining PAGBI capital | If a compliant first lot is purchased by 15 Apr, review sell-through at 15 May and 15 Jun. Minimum pilot gate: ≥60% of first-lot cost sold and cash collected within 60 days; realised gross margin at or above the SKU-specific floor approved before buying. Do not reorder slow-moving SKUs. Keep the remainder of the inventory allocation uncommitted until the gate passes. | 15 May and 15 Jun 2027; monthly thereafter | No second tranche unless ≥60% sell-through and cash collected within 60 days. Initial ₱30,000 is a maximum, not a target that must be spent. | PAGBI store lead; supplier representatives; farmer customers; bookkeeper. | Stock ageing report, cash collection record, SKU margin report, returns/expiry report and reorder sign-off. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Review technical evidence before claiming GolBi performance | By 30 Jun 2027, compile available approved test reports and raw records, including adverse outcomes, limitations, phytotoxicity observations, variability and cost per test. Hold a written go/repeat/pause meeting with the TAPI project officer and technical adviser. If independent efficacy or stability evidence is inconclusive, schedule only grant-approved follow-up work. Product marketing and sale remain gated by the applicable FPA authorization—not the TRL label alone. | Evidence pack 15 Jun; gate review 30 Jun | Within the ₱158,000 intact award and signed/approved TAPI lines only. No marketing spend; no commercial revenue assumed. | DOST-TAPI; FPA; approved laboratory; selected validation collaborators. | Final lab reports, raw data, batch record set, deviation log, authorized claims matrix and written next-step decision. |
| 2. Operational Efficiency & Productivity Owner: founder unless delegated | Stabilize the Tagetes supply chain; do not split the team into unfunded R&D | By 30 Jun 2027, request quotes/samples from at least 2 Tagetes raw-material sources and record harvest timing, minimum quantities, moisture/condition, location, delivery cost and consistency requirements. By 31 Aug, draft acceptance/rejection specs. Citronella or other botanicals may receive a literature and supplier-screening memo by 30 Sep only; no new formulation trial unless a partner or separate, documented budget pays for it and GolBi milestones are on schedule. | Supplier map 30 Jun; specs 31 Aug; alt-botanical gate 30 Sep | ₱0 new capital in base plan for citronella/new botanical formulations or microbial equipment. Samples/testing only with written budget source and approval. | Local Tagetes growers; Office of the Municipal Agriculturist; Davao de Oro Provincial Agriculturist’s Office; technical partners. | Supplier list, seasonal map, written specifications, quote/samples log, desk-study memo and funding gate. |
| 3. Organizational Strengthening Owner: founder unless delegated | Build one dashboard and enforce single-owner accountability | By 30 Apr 2027, implement a weekly sheet with four business-unit views: TerraSync, PAGBI, GolBi/TAPI and central overhead. By 30 Jun, complete SOPs for quote/deposit-to-delivery, PAGBI receiving/stock checks, grant-funded purchases and monthly closing. From Q3, review overdue actions and exceptions every Monday; at quarter-end document 3 largest failures, root causes and corrective actions. | Dashboard 30 Apr; core SOPs 30 Jun; weekly/monthly thereafter | ₱0 new subscriptions; use existing tools. Any paid tools require customer-funded need and cash-forecast approval. | Founder; assigned business-unit leads; accountant/bookkeeper if available. | Operating dashboard, SOP versions, KPI owner list, meeting notes and corrective-action register. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Expand only offers/products that pass margin and retention tests | By 31 Jul 2027, rank TerraSync offers using actual collected revenue, delivery hours, direct costs, revisions and time-to-payment. By 31 Aug, remove/reprice any offer with negative contribution or repeated scope creep. By 30 Sep, seek two recurring support clients. For PAGBI, add a SKU only if current supplier quote, registration, demand evidence and working-capital gate are documented. | 31 Jul offer ranking; 31 Aug pricing revisions; 30 Sep repeat-client gate | ₱0 paid ads in the base case. Any fulfilment cost funded from customer deposits/collections. No additional stock tranche solely to increase variety. | TerraSync clients; verified supplier channels; local customer referrals. | Job-level P&L; repeat-client records; service-level scope; inventory and SKU cohort report. |
| 4. Financial Health Owner: founder unless delegated | Prepare finance-backed external funding asks for remaining gaps | By 31 Aug 2027, cost the remaining GolBi validation gap from current test quotes, the missing microbial equipment list (prices only, no purchase), and 2028 operating runway. By 15 Sep, prepare a two-page milestone funding brief with the grant deliverables completed, independent evidence, customer interviews, actual unit economics, use of funds and no unsupported efficacy claims. Submit at least 2 well-matched applications/partner asks by 30 Sep only if eligible. | Cost gaps by 31 Aug; brief 15 Sep; submissions by 30 Sep | ₱0 application spend unless fee is documented, eligible and cash-approved. Do not buy microbial machines in anticipation of a grant. | DOST-TAPI/other eligible calls; qualified research institutions; possible investor/grant partners. | Validated budget gap, milestone evidence pack, matching-fund statement, application calendar and data room. |
| 1. Market Penetration/Expansion Owner: founder unless delegated | Make a formal scale / hold / stop decision | By 15 Oct 2027, review TerraSync paid conversion and repeat income; PAGBI permits, stock sell-through and realised SKU margins; GolBi test results/authorization; and the 13-week forecast. By 31 Oct, choose one documented decision for each unit: scale, maintain, pivot or pause. Do not widen geography or inventory without repeat demand and fulfilment capacity. | Scorecard 15 Oct; decisions signed by 31 Oct 2027 | No automatic growth budget. New capex/inventory needs a source of funds, signed quote, ROI/cash-conversion case, and ≥8 weeks’ fixed-cost cash cover after spending. | Owner/founder; accountant/bookkeeper; project officer; technical/regulatory advisers. | Unit-level P&L, KPI log, stock age, permits, test reports, 13-week forecast and signed decision memo. |
| 4. Financial Health Owner: founder unless delegated | Close 2027 and set 2028 budget from evidence | By 15 Nov 2027, close all accounts and review TAPI compliance, completed milestones and any authorized grant transactions, alongside the owner’s building debt/repayment obligations, PAGBI stock and other confidential funds disclosed in Q1. By 30 Nov, draft three 2028 scenarios (survival/base/upside) with assumptions for client work, authorized product sales only if approved, inventory turns, payroll/owner draw, taxes, payables and funding. By 15 Dec, approve a cash-limited 2028 plan; publish no claim of scale-readiness unless gates pass. | 15 Nov reconciliation; 30 Nov scenarios; 15 Dec approval; final close 31 Dec 2027 | ₱0 speculative capex. Budget sourced only from verified balances, collected operating profit or formally approved new capital/grants. | Owner/founder; accountant; DOST-TAPI project officer; relevant funding partners. | Year-end income/cash/stock statements, grant report checklist, scenario model, signed 2028 budget and board/owner decision log. |
Stop/go rules
Do not spend just because a budget line exists.
Any required permit is missing
No regulated retail, pesticide handling/repacking, or GolBi commercialization until the applicable local/FPA requirements and product authorization are confirmed in writing.
Grant line or cash source is unclear
Do not issue a PO. Match the item to the signed TAPI budget and procurement method, obtain any required written approval, or defer.
A spend is funded and reversible
An approved source of cash, current quote, positive contribution case, delivery plan and updated 13-week forecast must all be present. Prefer deposits, partner access and small test lots over permanent overhead.
Key Performance Indicators
Track outputs (what we did) and outcomes (what changed).
These are proposed targets for management review, not established historical performance. Adjust after the first 30–60 days of actual baseline data.
1. Market readiness and sales
Outcome indicators
Cash collected by business unitTrack monthly collected revenue—not quotes, pipeline value or unpaid invoices. Separate TerraSync, PAGBI and grants.Monthly
Repeat demand and customer retentionBy Q4, aim for at least 2 TerraSync clients on repeat work/maintenance; record repeat purchase rate once PAGBI is permitted.Quarterly
Output indicators
TerraSync prospect-to-cash funnelQ1 target: 10 qualified prospects and at least 2 paid pilot projects. Track leads, proposals, deposits, delivery time and project contribution margin.Weekly
Active sales channelsBy Q4, pursue 2 tested channels (e.g. direct B2B and partner referrals), only expanding after lead conversion is measured.Quarterly
2. Operational efficiency and compliance
Outcome indicators
Batch reproducibilityTarget 3 independently prepared batches assessed against predefined acceptance criteria, provided these fit the approved protocol and budget.At validation milestones
Safe, compliant activityZero sales/repacking activity outside the applicable licence/product authorization; verify written permit status before launching relevant activity.Before each activity
Output indicators
Grant-funded deliverables and records100% of scheduled eligible grant deliverables completed or explained by agreed deadlines; 100% of expenses have the required supporting documentation.Monthly / grant schedule
Stock and supplier controls100% of PAGBI SKUs have supplier invoice, current landed cost, expiry/lot record and price/margin calculation; maintain 3 quotes for material categories where feasible.Every purchase / weekly stock count
3. Organization and systems
Outcome indicators
Accountability100% of strategic KPIs have an owner, current status, next action and evidence link.Monthly
Decision speedHold one monthly close and one quarterly review; unresolved critical issues have a named owner and deadline.Monthly / quarterly
Output indicators
Separate ledgersMaintain distinct cost centres and bank/ledger classifications for TerraSync, PAGBI and PHYTOSPHERE R&D/TAPI.Every transaction
Operating proceduresCore SOPs for quoting/deposits, inventory, grant procurement, batch records and monthly finance review established by Q2.Q2 checkpoint
4. Financial health
Outcome indicators
Contribution marginPositive contribution after direct labour/time, freight, payment fees, packaging, discounts and other variable costs for each TerraSync offer and PAGBI SKU. Do not assume retail revenue means profit.Every project/SKU; monthly review
Cash disciplineQ4 target: two consecutive months where collected non-grant operating contribution covers routine operating outflow. If not achieved, activate a written survival plan and freeze discretionary spending.Monthly
Output indicators
Cash forecast and closing accountsUpdate the next 13 weeks every week; complete month-end close by the 5th working day; report weeks of cash coverage and overdue payables.Weekly / monthly
Funding readinessBy Q4, prepare a 2028 financing case with verified costs, milestones, sales evidence and funding requirements; pursue at least 2 suitable support opportunities only when eligible.Quarterly
Control thresholds
Every KPI needs a response when it misses.
Proposed management targets, not industry benchmarks. Validate after the first 30–60 days of actual data.
| Metric | Target / trigger | Review | What to do if missed |
|---|---|---|---|
| 13-week cash forecast | Updated weekly; all known bills and confirmed receipts included. | Every Monday | If less than 8 weeks of fixed costs are covered after planned spend, freeze optional spending. If under 4 weeks, stop nonessential procurement, collect receivables, negotiate payables early and create a survival budget. |
| TAPI grant compliance and reporting | 100% of grant-funded purchases matched to approved line items and supporting documents; required technical and financial reports filed on schedule. | Now, then monthly | Pause non-urgent grant procurement; reconcile receipts and commitments; ask the project officer in writing about variances before reallocating. |
| TerraSync paid validation | At least 2 paid pilot jobs by end of Q1; seek an advance deposit of at least 50% for custom work where commercially appropriate. | Weekly pipeline | After 30 qualified prospect contacts without a paid pilot, narrow the offer, revise the value proposition/price and interview lost prospects. Do not respond by buying ads or adding software. |
| TerraSync contribution | Positive contribution per project after direct labor/time, tools, fees, hosting and revisions. | After every job; monthly | Increase price, narrow scope, reduce revisions, require milestone payments or stop offering the unprofitable package. |
| PAGBI launch authorization | 100% of the required local permits/FPA authorizations verified before the applicable sales, handling or repacking activity. | Before opening / activity | Do not launch that activity; keep stock orders on hold where appropriate; ask the relevant agency for written clarification. |
| PAGBI first inventory tranche | Initial order ≤₱30,000; aim for at least 60% sell-through in 60–90 days. Proposed internal gate, not an industry standard. | Weekly counts; monthly sell-through | No replenishment if sell-through is below threshold. Review SKU selection, price, location, seasonality and supplier terms; do not increase capital committed. |
| PAGBI SKU margin | Every SKU has current landed cost, expiry/lot record and realised margin. Proposed minimum gate: 15% gross margin after direct landed cost, adjusted by category economics. | Before order and monthly | If margin is below the approved floor, renegotiate, reprice where customers accept it, select another SKU or stop stocking it. Requote before purchasing. |
| GolBi validation milestones | 100% of scheduled grant deliverables completed or formally explained; batches/tests meet written acceptance criteria. | Per protocol / monthly | Document failure and root cause. Repeat only when approved and funded. Do not claim proven efficacy or sell without applicable authorization. |
| Microbial R&D spending | ₱0 machine/equipment capital in base plan until dedicated funding and market/technical case are documented. | Quarterly | Defer purchase. Pursue in-kind access, university/lab partnership, or a dedicated grant only if the project does not threaten cash survival. |
| Supplier price volatility | Current quote for every important reorder; 3 quotes where feasible; reconfirm quotes older than 7 days. | Before each purchase | Recalculate landed cost and margin; delay discretionary buys if cost changed materially or customer prices cannot absorb the increase. |
| Owner borrowing vs. TAPI classification | By 23 Oct 2026, record the ~₱70,000 building borrowing as a separate debt/liability and document that no building amount is charged to TAPI; keep the ₱158,000 award intact and ring-fenced for approved validation. | 22–23 Oct, then every month | Stop any expense that lacks a valid source, loan record, approved grant line or supporting documents. Keep the debt repayment calendar and TAPI grant ledger separate. |
| Other confidential funds report | Owner submits the Q1 2027 internal report by 31 Mar 2027: source, amount, bank/cash status, restrictions, repayment terms, liabilities and evidence. | 31 Jan draft; 28 Feb check; 31 Mar final | Keep the amount outside the cash forecast and assign ₱0 to commitments until formally disclosed and verified. |
| PAGBI supplier/source validation | At least 3 written quotes by 14 Nov 2026; 100% of selected products and sellers rechecked in current FPA lists before purchase. | 14 Nov 2026; then every order | No purchase order. Obtain fresh quotes, verify product registration and seller authorization, and update landed cost and expiry-risk calculation. |
KPI rule: record a baseline before reporting improvement. Count cash received, not expected revenue; count registered/licensed status only from official evidence; count test results only from documented protocols and reports.
The 2027 sequence
Do the work in the order that reduces risk.
Quarterly plans can change with permits, grant deadlines, supplier prices and customer response. Review each quarter as a decision gate, not a promise to scale.
Secure the basics
- Confirm local permits and FPA status applicable to each activity.
- Close grant reconciliation and use approved work plan as the test schedule.
- Launch TerraSync offers and collect first paid projects/deposits.
- Hold weekly 13-week cash reviews.
Output: clean cash baseline, paid pilot activity, compliant launch gates.
Prove the economics
- Evaluate GolBi validation results and batch records.
- Test actual time, price and contribution margin for TerraSync work.
- Start PAGBI only after permits; stock a narrow, quote-checked mix.
- Review inventory age and cash collections monthly.
Output: first reliable unit-economics and product-validation evidence.
Standardize what works
- Improve SOPs based on deviations and customer feedback.
- Seek repeat service contracts and supplier terms.
- Only test wider distribution when replenishment and margins work.
- Seek funding partners around specific gaps, not broad ideas.
Output: lower delivery variability and repeatable cash-generating workflows.
Make a scale decision
- Review cash flow, client repeat work, stock sell-through and payables.
- Determine whether GolBi has the evidence and approvals for its next stage.
- Hold microbial capital expenditure unless separately funded.
- Write the 2028 investment case and downside plan.
Output: evidence-led go / pause / stop decision and 2028 plan.
Rules to scale
Five gates must pass before PHYTOSPHERE commits to a bigger operation.
01
Authorization
Required local business permits, applicable FPA licences and product-specific authorizations are documented for the exact activity.
02
Product consistency
Testing is completed, batch criteria are met and the evidence package is complete. No marketing promise should exceed the evidence.
03
Customer proof
At least repeat purchase or validated willingness to pay—not only awards, likes, interest or unpaid demos.
04
Positive economics
Every product/service has its fully loaded cost, contribution margin, fulfillment cost and working-capital cycle understood.
05
Cash resilience
No scale-up capex unless the rolling forecast covers committed costs and leaves a proposed minimum eight weeks of fixed-cost coverage after the spend.
!
Fail a gate? Pause.
Freeze discretionary purchases, focus on TerraSync cash collections and permitted PAGBI sales, complete grant obligations, and re-test the plan.
The proposed eight-week cash coverage is an internal management guardrail, not a legal or industry standard. Adapt it after calculating actual weekly fixed costs.
Reference links
Sources to check as the plan changes.
Market conditions, price references and official application requirements change. The links below support the planning assumptions and should be checked again before purchasing, licensing or expanding.
Before financial decisions: use the signed DOST-TAPI grant agreement, actual bank records, receipts, open purchase orders and official FPA/municipal responses as the controlling records. This plan is a management aid, not a replacement for your accountant, grant officer or regulator.